Filing Details
- Accession Number:
- 0000914190-19-000370
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-09-11 16:42:41
- Reporting Period:
- 2019-09-09
- Accepted Time:
- 2019-09-11 16:42:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 842023 | Bio-Techne Corp | TECH | Biological Products, (No Disgnostic Substances) (2836) | 411427402 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1534980 | R. Charles Kummeth | 614 Mckinley Place Ne Minneapolis MN 55413 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-09-09 | 100 | $185.00 | 100 | No | 4 | P | Indirect | By Step-Son |
| Common Stock | Acquisiton | 2019-09-09 | 100 | $185.00 | 100 | No | 4 | P | Indirect | By Step-Daughter |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By Step-Son |
| No | 4 | P | Indirect | By Step-Daughter |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 135,856 | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | $67.46 | 2020-04-01 | 57,590 | 57,590 | Direct | |
| Common Stock | Stock Options (Right to Buy) | $86.25 | 2021-04-01 | 46,316 | 46,316 | Direct | |
| Common Stock | Stock Options (Right to Buy) | $94.35 | 2021-08-12 | 66,849 | 66,849 | Direct | |
| Common Stock | Stock Options (Right to Buy) | $108.49 | 2022-08-07 | 95,346 | 95,346 | Direct | |
| Common Stock | Stock Options (Right to Buy) | $108.49 | 2022-08-07 | 79,517 | 79,517 | Direct | |
| Common Stock | Stock Options (Right to Buy) | $106.59 | 2023-08-18 | 154,169 | 154,169 | Direct | |
| Common Stock | Stock Options (Right to Buy) | $106.59 | 2023-08-18 | 102,779 | 102,779 | Direct | |
| Common Stock | Restricted Stock Units | $0.00 | 21,291 | 21,291 | Direct | ||
| Common Stock | Stock Options (Right to Buy) | $125.05 | 2024-08-09 | 117,342 | 117,342 | Direct | |
| Common Stock | Stock Options (Right to Buy) | $125.05 | 2024-08-09 | 78,228 | 78,228 | Direct | |
| Common Stock | Restricted Stock Units | $0.00 | 16,918 | 16,918 | Direct | ||
| Common Stock | Stock Options (Right to Buy) | $177.32 | 2025-08-08 | 90,334 | 90,334 | Direct | |
| Common Stock | Stock Options (Right to Buy) | $177.32 | 2025-08-08 | 60,222 | 60,222 | Direct | |
| Common Stock | Restricted Stock Units | $0.00 | 16,937 | 16,937 | Direct | ||
| Common Stock | Stock Options (Right to Buy) | $190.41 | 2026-08-07 | 85,725 | 85,725 | Direct | |
| Common Stock | Stock Options (Right to Buy) | $190.41 | 2026-08-07 | 57,150 | 57,150 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2020-04-01 | 57,590 | 57,590 | Direct |
| 2021-04-01 | 46,316 | 46,316 | Direct |
| 2021-08-12 | 66,849 | 66,849 | Direct |
| 2022-08-07 | 95,346 | 95,346 | Direct |
| 2022-08-07 | 79,517 | 79,517 | Direct |
| 2023-08-18 | 154,169 | 154,169 | Direct |
| 2023-08-18 | 102,779 | 102,779 | Direct |
| 21,291 | 21,291 | Direct | |
| 2024-08-09 | 117,342 | 117,342 | Direct |
| 2024-08-09 | 78,228 | 78,228 | Direct |
| 16,918 | 16,918 | Direct | |
| 2025-08-08 | 90,334 | 90,334 | Direct |
| 2025-08-08 | 60,222 | 60,222 | Direct |
| 16,937 | 16,937 | Direct | |
| 2026-08-07 | 85,725 | 85,725 | Direct |
| 2026-08-07 | 57,150 | 57,150 | Direct |
Footnotes
- Includes (i) 4,732 shares of restricted stock for which the risk of forfeiture will lapse on August 9, 2020; (ii) 7,519 shares of restricted stock for which the risk of forfeiture will lapse as to 3,760 shares on August 8, 2020 and as to 3,759 shares on August 8, 2021; and (iii) 11,291 shares of restricted stock for which the risk of forfeiture will lapse with respect to 3,764 shares on each of August 7, 2020 and August 7, 2021 and as to 3,763 shares on August 7, 2022.
- Fully exercisable.
- Options to purchase 25,695 shares vest on each of 8/18/2017, 8/18/2018 and 8/18/2019 and options to purchase 25,695 shares vest on 8/18/2020.
- Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
- Vests in full or in part on 8/9/2020 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- Options to purchase 19,557 shares vest on each of 8/9/2018, 8/9/2019, 8/9/2020 and 8/9/2021.
- Vests in full or in part on 8/8/2021 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- Options to purchase 15,056 shares vest on each of 8/8/2019 and 8/8/2020 and options to purchase 15,055 shares vest on each of 8/8/2021 and 8/8/2022.
- Vests in full or in part on 8/7/2022 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- Options to purchase 14,288 shares vest on each of 8/7/2020 and 8/7/2021 and options to purchase 14,287 shares vest on each of 8/7/2022 and 8/7/2023.
Billionaire Hedge Funds
